TGF-β1 increased Snail expression in cultured ARPE-19 cells. by Hui Li (32376)

“…The increasing expression of mesenchymal markers fibronectin (B) and α-SMA (C) and the decreasing expression of epithelial markers E-cadherin (D) and ZO-1 (E). …”

Metformin does not further increase the median lifespan of DR-constitutive mutant eat-2, and metformin treatment triggers several DR phenotypes in wild-type <i>C. elegans</i> witho... by Brian Onken (86790)

“…<p><b>A.</b> Survival curves of <i>eat-2(ad1116)</i> mutants raised on 0 mM, 1 mM, 10 mM, and 50 mM metformin plates at 20°C. …”

Telomere length regulates Fst/BMP/pSmad signaling. by Na Liu (102929)

“…<p>(A) Scatter plots showing global differential gene expression profile of WT and G4 <i>Terc</i>^–/–ES cells. …”

DataSheet_1_Immune responses during COVID-19 breakthrough cases in vaccinated children and adolescents.pdf by Daniela Rivera-Pérez (10700565)

Variation of average codeword length (ACL) by number of edges. by Dario Elias (8882177)

“…A positive variation indicates a decrease in the ACL. …”

B-Myb binds to and regulates Oct4 promoter activity. by Kirill V. Tarasov (75912)

“…In undifferentiated cells, an amplification signal 10–15-fold above that seen in the IgG control is observed; however, this signal is reduced to only 2–4 fold above the IgG control following withdrawal of LIF and FCS. …”

FIGURE 1 from D-2-HG Inhibits <i>IDH1^mut</i> Glioma Growth via FTO Inhibition and Resultant m6A Hypermethylation by Sean T. Pianka (18237413)

“…Note that the total RADAR gene number is slightly larger here than the totals in <b>J</b>, because this list includes all <i>P</i> < 0.01 transcripts (including those with low magnitude fold changes). <b>L,</b> Supervised hierarchical clustering heat map of intersectional TCGA and RADAR data between U87, NHA, and gliomasphere cell lines that conformed to m6A and RNA expression conventions (i.e., an increase in RADAR m6A expression corresponded to a decrease in TCGA RNA expression). …”

The kava root extract and kavalactones down-regulate expression of AR and AR target genes (<i>PSA</i> and <i>TMPRSS2</i>) via accelerating the degradation of AR protein. by Xuesen Li (48046)

“…The protein expression of AR and PSA in LNCaP and C4-2B cells after indicated treatments at a concentration of their IC_{50 s} for 16 hours was analyzed by Western blot. α-Tubulin was detected as a loading control. …”

Circular Dichroism analysis, PPIase activity and nickel regulation of <i>H</i>. <i>pylori</i> WT and mutant SlyD proteins. by Milica Denic (9987685)

Optimal hydrated lime concentration in asphalt binder to improve photo degradation resistance by André Gustavo Banja (5110844)

Scutellarin’s Cardiovascular Endothelium Protective Mechanism: Important Role of PKG-I<i>α</i> by Lin Li (28817)

“…The activation of PKG–1α was then studied using targeted proteomic analysis (MRM-MS) checking the phosphorylation state of the autophosphorylation domain (aa42-94). Significant decrease in phosphorylation of PKG-Iα at Ser50, Ser72, Ser89 was induced by HR injury while SCU treatment significantly increased the phosphorylation of PKG-Iα, not only at Ser50, Ser72 and Ser89, but also at Ser44 and Thr58 (two novel phosphorylation domains). …”

Histone deacetylase (HDAC) inhibitor assessment. by Ilona Tkachyova (343715)

“…ITF 2357, an HDAC inhibitor which is structurally and functionally similar to SAHA, produced a dose-response curve with IC₅₀ of 0.2 μM. …”

Plk1 inhibition suppresses the clonogenic potential of SUM149 and SUM159. by Antonio Giordano (55096)

“…(B) EC₅₀ was defined as 50% colony inhibition. Single agents EC₅₀ were reported for each TNBC cell line and drug. …”

Image2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image1_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.jpeg by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table3_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Image4_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.pdf by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”

Table2_Peripheral blood T-cell modulation by omalizumab in chronic urticaria patients.docx by Cristina López (2841392)

“…</p>Results<p>In patients with CSU under treatment with omalizumab, there was a significant decrease in the percentage of naïve and an increase in the percentage of central memory CD4 T cells as well as a decrease in the percentage of naïve and increase in the percentage of effector CD8 T-cell subsets. …”